Detection of anxiety disorders in primary care: A meta‐analysis of assisted and unassisted diagnoses E Olariu, CG Forero, JI Castro‐Rodriguez, MT Rodrigo‐Calvo, P Álvarez, ... Depression and Anxiety 32 (7), 471-484, 2015 | 86 | 2015 |
Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin. SV Tost M, Monreal JA, Armario A, Barbero JD, Cobo J, García-Rizo C, Bioque ... Clin Drug Investig. 40 (1), 1-14, 2020 | 59 | 2020 |
Altered [3H] imipramine and 5-HT2 but not [3H] paroxetine binding sites in platelets from depressed patients P Rosel, B Arranz, J Vallejo, P Alvarez, JM Menchon, T Palencia, ... Journal of affective disorders 52 (1-3), 225-233, 1999 | 53 | 1999 |
Early‐and late‐onset depression in the older: no differences found within the melancholic subtype P Alvarez, M Urretavizcaya, L Benlloch, J Vallejo, JM Menchón International journal of geriatric psychiatry 26 (6), 615-621, 2011 | 34 | 2011 |
Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain P Rosel, JM Menchon, M Oros, J Vallejo, T Cortadellas, B Arranz, ... Journal of neural transmission 104 (1), 89-96, 1997 | 28 | 1997 |
High affinity [3H] imipramine and [3H] paroxetine binding sites in suicide brains P Rosel, B Arranz, J Vallejo, M Oros, JM Menchon, P Alvarez, MA Navarro Journal of neural transmission 104, 921-929, 1997 | 26 | 1997 |
Platelet [3H] imipramine and [3H] paroxetine binding in depressed patients P Rosel, JM Menchon, J Vallejo, B Arranz, MA Navarro, F Liron, P Alvarez Journal of affective disorders 44 (1), 79-85, 1997 | 23 | 1997 |
Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder Y Sánchez‐Carro, MJ Portella, I Leal-Leturia, N Salvat‐Pujol, M Etxandi, ... Journal of Affective Disorders 279, 343-352, 2021 | 16 | 2021 |
Concurrent Koro and Cotard syndromes in a Spanish male patient with a psychotic depression and cerebrovascular disease P Alvarez, VM Puente, MJ Blasco, P Salgado, A Merino, A Bulbena Psychopathology 45 (2), 126-129, 2012 | 15 | 2012 |
Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning Y Sánchez-Carro, A de la Torre-Luque, I Leal-Leturia, N Salvat-Pujol, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 121, 110674, 2023 | 13 | 2023 |
Validation of clinical symptom IRT scores for diagnosis and severity assessment of common mental disorders E Olariu, JI Castro-Rodriguez, P Álvarez, C Garnier, M Reinoso, ... Quality of Life Research 24, 979-992, 2015 | 9 | 2015 |
Change in functioning outcomes as a predictor of the course of depression: a 12-month longitudinal study CG Forero, E Olariu, P Álvarez, JI Castro-Rodriguez, MJ Blasco, G Vilagut, ... Quality of Life Research 27, 2045-2056, 2018 | 8 | 2018 |
Asking patients about their general level of functioning: Is IT worth IT for common mental disorders? E Olariu, CG Forero, P Alvarez, JI Castro-Rodriguez, MJ Blasco, J Alonso, ... Psychiatry Research 229 (3), 791-800, 2015 | 8 | 2015 |
Relationship between immunometabolic status and cognitive performance among major depression disorder patients Y Sánchez-Carro, A de la Torre-Luque, MJ Portella, I Leal-Leturia, ... Psychoneuroendocrinology 137, 105631, 2022 | 6 | 2022 |
Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report P Alvarez, E Papaseit, V Pérez, A Bulbena, M Farré Actas Españolas de Psiquiatría 47 (1), 33-36, 2019 | 4 | 2019 |
Lithium: The survivor that came from the stars. P Álvarez, P Salgado, V Pérez‐Solá Bipolar Disorders 21 (5), 2019 | 2 | 2019 |
P. 0363 Relevance of immunometabolic status for the evaluation of cognitive performance in patients with major depressive disorder Y Sánchez-Carro, A De la Torre-Luque, I Leal-Leturia, ... European Neuropsychopharmacology 53, S264-S265, 2021 | | 2021 |
Clinical severity and physical activity predict cognitive impairment in major depressive disorder. Y Sánchez Carro, M Portella, I Leal Leturia, N Salvat, V Soria, P Alvarez, ... European Psychiatry 63, 2020 | | 2020 |
P. 611 Biomarkers of inflammation and neural plasticity in olfactory neuroepithelium-derived cells from patients with major depressive disorder P Álvarez, JM Gines, C Fernández, A Toll, C Díez-Aja, LM Martín, ... European Neuropsychopharmacology, 2019, vol. 29, supl. 6, p. S418-S419, 2019 | | 2019 |
Alteración reversible del gusto y del olfato asociada con valproato sódico y quetiapina en la depresión bipolar: a propósito de un caso P Álvarez López, E Papaseit Fontanet, V Pérez Solá, A Bulbena Vilarrasa, ... Elsevier, 2019 | | 2019 |